These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33060050)

  • 1. Spontaneous Regression of High-Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements: Case Report and Literature Review.
    Stanoszek LM; Smith LB; Grajewski K; Reneau JC; Wilcox R; Perry AM
    Clin Lymphoma Myeloma Leuk; 2021 Feb; 21(2):e120-e125. PubMed ID: 33060050
    [No Abstract]   [Full Text] [Related]  

  • 2. High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor Prognosis.
    Li S; Weiss VL; Wang XJ; Desai PA; Hu S; Yin CC; Tang G; Reddy NM; Medeiros LJ; Lin P
    Am J Surg Pathol; 2016 Feb; 40(2):253-61. PubMed ID: 26448193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Approach for Double-Hit and Triple-Hit Lymphoma Based on Immunophenotypic and Cytogenetic Characteristics of Bone Marrow Specimens.
    Kim H; Kim HJ; Kim SH
    Ann Lab Med; 2020 Sep; 40(5):361-369. PubMed ID: 32311849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-grade B-cell lymphoma with MYC and BCL2 rearrangements presenting as a cervical mass.
    Lin C; Kuma L; Shen L
    Pathology; 2024 Jun; 56(4):588-590. PubMed ID: 37940480
    [No Abstract]   [Full Text] [Related]  

  • 5. Triple-hit B-cell Lymphoma With MYC, BCL2, and BCL6 Translocations/Rearrangements: Clinicopathologic Features of 11 Cases.
    Wang W; Hu S; Lu X; Young KH; Medeiros LJ
    Am J Surg Pathol; 2015 Aug; 39(8):1132-9. PubMed ID: 25828391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary thyroid high-grade B-cell lymphoma with MYC and BCL2 rearrangements in Hashimoto's thyroiditis.
    Tariq H; Zahra U
    Diagn Cytopathol; 2022 Feb; 50(2):84-85. PubMed ID: 34962105
    [No Abstract]   [Full Text] [Related]  

  • 7. Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes.
    Lue JK; Luttwak E; Rivas-Delgado A; Irawan H; Boardman A; Caron PC; David K; Epstein-Peterson Z; Falchi L; Ghione P; Hamlin P; Horwitz SM; Intlekofer AM; Johnson W; Kumar A; Moskowitz A; Noy A; Palomba ML; Steiner R; Stuver R; Torka P; Vardhana S; Zelenetz AD; Schoder H; Imber B; Yahalom J; Zhang Y; Galera P; Dogan A; Aypar U; Salles G
    Blood Cancer J; 2024 Oct; 14(1):178. PubMed ID: 39402034
    [No Abstract]   [Full Text] [Related]  

  • 8. Unexpected favorable outcome in a patient with high grade B-cell lymphoma with abnormalities of MYC, BCL6 and BCL2 loci.
    Adams T; Fuchs D; Shadoan PK; Johnstone L; Lau BM; McGhan L; Anwer F; Al-Kateb H
    Cancer Genet; 2018 Apr; 222-223():25-31. PubMed ID: 29666005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Triple hit" lymphomas: A retrospective cytology case series of an uncommon high grade B-cell malignancy with C-MYC, BCL-2 and BCL-6 rearrangements.
    Eldessouki T; Hanley K; Hamadeh F; Oshilaja OO; Sturgis CD
    Diagn Cytopathol; 2018 Sep; 46(9):807-811. PubMed ID: 30043475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-grade B-Cell Lymphoma With MYC, BCL2, and/or BCL6 Translocations/Rearrangements: Clinicopathologic Features of 51 Cases in a Single Institution of South China.
    Zhang J; Weng Z; Huang Y; Li M; Wang F; Wang Y; Rao H
    Am J Surg Pathol; 2020 Dec; 44(12):1602-1611. PubMed ID: 32991338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.
    Snuderl M; Kolman OK; Chen YB; Hsu JJ; Ackerman AM; Dal Cin P; Ferry JA; Harris NL; Hasserjian RP; Zukerberg LR; Abramson JS; Hochberg EP; Lee H; Lee AI; Toomey CE; Sohani AR
    Am J Surg Pathol; 2010 Mar; 34(3):327-40. PubMed ID: 20118770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYC/BCL2 double-hit high-grade B-cell lymphoma.
    Li S; Lin P; Young KH; Kanagal-Shamanna R; Yin CC; Medeiros LJ
    Adv Anat Pathol; 2013 Sep; 20(5):315-26. PubMed ID: 23939148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYC and BCL2 evaluation in routine diagnostics of aggressive B-cell lymphomas - presentation of a work-flow and the experience with 248 cases.
    Menter T; Medani H; Ahmad R; Flora R; Trivedi P; Reid A; Naresh KN
    Br J Haematol; 2017 Nov; 179(4):681-684. PubMed ID: 27447126
    [No Abstract]   [Full Text] [Related]  

  • 14. Elucidating a false-negative
    Peterson JF; Pitel BA; Smoley SA; Vasmatzis G; Smadbeck JB; Greipp PT; Ketterling RP; Macon WR; Baughn LB
    Cold Spring Harb Mol Case Stud; 2019 Jun; 5(3):. PubMed ID: 31160360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma.
    Huang S; Nong L; Wang W; Liang L; Zheng Y; Liu J; Li D; Li X; Zhang B; Li T
    Diagn Pathol; 2019 Jul; 14(1):81. PubMed ID: 31315646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DA-EPOCH-R therapy for high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements in a patient with renal dysfunction.
    Mitobe M; Kawamoto K; Suzuki T; Suwabe T; Shibasaki Y; Masuko M; Inoue K; Miyoshi H; Ohshima K; Sone H; Takizawa J
    J Clin Exp Hematop; 2021 Mar; 61(1):42-47. PubMed ID: 33551436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous involvement of high-grade B-cell lymphoma with MYC and BCL6 rearrangements: A case report.
    Maejima E; Oishi N; Ogawa Y; Okamoto T; Mitsui H; Shimada S; Kawamura T
    J Dermatol; 2023 Aug; 50(8):e243-e244. PubMed ID: 36890662
    [No Abstract]   [Full Text] [Related]  

  • 18. Inferior survival in high-grade B-cell lymphoma with
    McPhail ED; Maurer MJ; Macon WR; Feldman AL; Kurtin PJ; Ketterling RP; Vaidya R; Cerhan JR; Ansell SM; Porrata LF; Nowakowski GS; Witzig TE; Habermann TM
    Haematologica; 2018 Nov; 103(11):1899-1907. PubMed ID: 29903764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EBV-positive low-grade follicular lymphoma transforming to EBV-negative high-grade B-cell lymphoma with MYC and BCL2 rearrangements.
    Nam MH; Hsieh YY; Chen BJ
    Pathology; 2022 Aug; 54(5):634-636. PubMed ID: 34872752
    [No Abstract]   [Full Text] [Related]  

  • 20. Coexistence of MYC/BCL2 double-hit of t(8;14)(q24;q32) and t(14;18)(q32;q21) and that of t(8;22)(q24;q11) and t(14;18) in advanced-stage high-grade B cell lymphoma.
    Takeoka K; Nakagawa M; Kishimori C; Fukutsuka K; Maekawa F; Hayashida M; Ohno H
    Ann Hematol; 2021 Dec; 100(12):3043-3045. PubMed ID: 32895753
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.